Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)
1 other identifier
observational
100
1 country
15
Brief Summary
This is an observational epidemiologic multicentric study of follow-up a cohort for described the situation of patients with primary ovarian insufficiency in public population with respect to the age of apparition the primary ovarian insufficiency . iPOI (Investigators in premature ovarian insufficiency): M. Guinot, B. Roca, J. Tomás, P. Escamilla, J. Hernández, P. Llaneza, N. Mendoza Ladrón de Guevara, B. Otero García, I. Ñiguez, A. Castro, L. Baquedano, P. Romero, S. Sánchez.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2013
Longer than P75 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2013
CompletedFirst Submitted
Initial submission to the registry
February 17, 2014
CompletedFirst Posted
Study publicly available on registry
February 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedMay 10, 2022
May 1, 2022
10.1 years
February 17, 2014
May 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Age
Age when diagnosed primary ovarian insufficiency
Day 0
Study Arms (1)
Women with Primary Ovarian Insufficiency
Eligibility Criteria
Patients procedints of gynecology deparment of the centers participants
You may qualify if:
- Women between 18 years and 39 years.
- Primary ovarian insufficiency demonstrated with amenorrhea and levels of follicle stimulating hormone (FSH) over to 40 IU in two determinations measured with a difference of one moth.
- Not present linguistic barriers ,shaw attitude towards collaboration ,be able to attend the study center for all follow-up visits.
You may not qualify if:
- Women with secondary hormonal alteration that do no meet the diagnostic criteria of the disease.
- Refusal to participate.
- Withdrawal of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
Hospital Universitari General de Catalunya
Sant Cugat del Vallès, Barcelona, Spain
Hospital Universitario Materno Infantil de Canarias
Las Palmas de Gran Canaria, Las Palmas, Spain
Hospital de Manacor
Manacor, Palma de Mallorca, Spain
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
Hospital de Poniente de El Egido
Almería, Spain
Complejo Asistencial de Avila
Ávila, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, 08025, Spain
Hospital Terrasa
Barcelona, Spain
Hospital Universitari Mutua de Terrasa
Barcelona, Spain
Hospital Universitario de Cruces
Bilbao, Spain
Hospital Universitario Virgen de las Nieves
Granada, Spain
Universidad de Granada
Granada, Spain
Grupo Hospitalario Perpetuo Socorro
Lleida, Spain
HCU Virgen de la Arrixaca
Murcia, Spain
Hospital Universitario Miguel Servet
Zaragoza, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Misericordia Guinot, MD PhD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2014
First Posted
February 21, 2014
Study Start
November 28, 2013
Primary Completion
January 1, 2024
Study Completion
June 1, 2024
Last Updated
May 10, 2022
Record last verified: 2022-05